These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Genetic variants in COL13A1, ADIPOQ and SAMM50, in addition to the PNPLA3 gene, confer susceptibility to elevated transaminase levels in an admixed Mexican population. Larrieta-Carrasco E; Flores YN; Macías-Kauffer LR; Ramírez-Palacios P; Quiterio M; Ramírez-Salazar EG; León-Mimila P; Rivera-Paredez B; Cabrera-Álvarez G; Canizales-Quinteros S; Zhang ZF; López-Pérez TV; Salmerón J; Velázquez-Cruz R Exp Mol Pathol; 2018 Feb; 104(1):50-58. PubMed ID: 29307798 [TBL] [Abstract][Full Text] [Related]
5. More Evidence for the Genetic Susceptibility of Mexican Population to Nonalcoholic Fatty Liver Disease through PNPLA3. Chinchilla-López P; Ramírez-Pérez O; Cruz-Ramón V; Canizales-Quinteros S; Domínguez-López A; Ponciano-Rodríguez G; Sánchez-Muñoz F; Méndez-Sánchez N Ann Hepatol; 2018 Mar; 17(2):250-255. PubMed ID: 29469042 [TBL] [Abstract][Full Text] [Related]
6. The 148M allele of the PNPLA3 gene is associated with indices of liver damage early in life. Romeo S; Sentinelli F; Cambuli VM; Incani M; Congiu T; Matta V; Pilia S; Huang-Doran I; Cossu E; Loche S; Baroni MG J Hepatol; 2010 Aug; 53(2):335-8. PubMed ID: 20546964 [TBL] [Abstract][Full Text] [Related]
7. Association between PNPLA3 (rs738409), LYPLAL1 (rs12137855), PPP1R3B (rs4240624), GCKR (rs780094), and elevated transaminase levels in overweight/obese Mexican adults. Flores YN; Velázquez-Cruz R; Ramírez P; Bañuelos M; Zhang ZF; Yee HF; Chang SC; Canizales-Quinteros S; Quiterio M; Cabrera-Alvarez G; Patiño N; Salmerón J Mol Biol Rep; 2016 Dec; 43(12):1359-1369. PubMed ID: 27752939 [TBL] [Abstract][Full Text] [Related]
8. The association of PNPLA3 variants with liver enzymes in childhood obesity is driven by the interaction with abdominal fat. Giudice EM; Grandone A; Cirillo G; Santoro N; Amato A; Brienza C; Savarese P; Marzuillo P; Perrone L PLoS One; 2011; 6(11):e27933. PubMed ID: 22140488 [TBL] [Abstract][Full Text] [Related]
9. Associations of I148M variant in PNPLA3 gene with plasma ALT levels during 2-year follow-up in normal weight and overweight children: the PANIC Study. Viitasalo A; Pihlajamaki J; Lindi V; Atalay M; Kaminska D; Joro R; Lakka TA Pediatr Obes; 2015 Apr; 10(2):84-90. PubMed ID: 24916969 [TBL] [Abstract][Full Text] [Related]
10. Paradoxical lower serum triglyceride levels and higher type 2 diabetes mellitus susceptibility in obese individuals with the PNPLA3 148M variant. Palmer CN; Maglio C; Pirazzi C; Burza MA; Adiels M; Burch L; Donnelly LA; Colhoun H; Doney AS; Dillon JF; Pearson ER; McCarthy M; Hattersley AT; Frayling T; Morris AD; Peltonen M; Svensson PA; Jacobson P; Borén J; Sjöström L; Carlsson LM; Romeo S PLoS One; 2012; 7(6):e39362. PubMed ID: 22724004 [TBL] [Abstract][Full Text] [Related]
11. Morbid obesity exposes the association between PNPLA3 I148M (rs738409) and indices of hepatic injury in individuals of European descent. Romeo S; Sentinelli F; Dash S; Yeo GS; Savage DB; Leonetti F; Capoccia D; Incani M; Maglio C; Iacovino M; O'Rahilly S; Baroni MG Int J Obes (Lond); 2010 Jan; 34(1):190-4. PubMed ID: 19844213 [TBL] [Abstract][Full Text] [Related]
12. The I148M PNPLA3 polymorphism influences serum adiponectin in patients with fatty liver and healthy controls. Valenti L; Rametta R; Ruscica M; Dongiovanni P; Steffani L; Motta BM; Canavesi E; Fracanzani AL; Mozzi E; Roviaro G; Magni P; Fargion S BMC Gastroenterol; 2012 Aug; 12():111. PubMed ID: 22898488 [TBL] [Abstract][Full Text] [Related]
13. Association of the I148M/PNPLA3 (rs738409) polymorphism with premature coronary artery disease, fatty liver, and insulin resistance in type 2 diabetic patients and healthy controls. The GEA study. Posadas-Sánchez R; López-Uribe ÁR; Posadas-Romero C; Pérez-Hernández N; Rodríguez-Pérez JM; Ocampo-Arcos WA; Fragoso JM; Cardoso-Saldaña G; Vargas-Alarcón G Immunobiology; 2017 Oct; 222(10):960-966. PubMed ID: 27615511 [TBL] [Abstract][Full Text] [Related]
15. Patatin-like phospholipase domain-containing 3 I148M affects liver steatosis in patients with chronic hepatitis B. Viganò M; Valenti L; Lampertico P; Facchetti F; Motta BM; D'Ambrosio R; Romagnoli S; Dongiovanni P; Donati B; Fargion S; Colombo M Hepatology; 2013 Oct; 58(4):1245-52. PubMed ID: 23564580 [TBL] [Abstract][Full Text] [Related]
16. Association between variants in or near PNPLA3, GCKR, and PPP1R3B with ultrasound-defined steatosis based on data from the third National Health and Nutrition Examination Survey. Hernaez R; McLean J; Lazo M; Brancati FL; Hirschhorn JN; Borecki IB; Harris TB; ; Nguyen T; Kamel IR; Bonekamp S; Eberhardt MS; Clark JM; Kao WH; Speliotes EK Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1183-1190.e2. PubMed ID: 23416328 [TBL] [Abstract][Full Text] [Related]
17. Novel association between a nonsynonymous variant (R270H) of the G-protein-coupled receptor 120 and liver injury in children and adolescents with obesity. Marzuillo P; Grandone A; Conte M; Capuano F; Cirillo G; Di Sessa A; Umano GR; Romano R; Perrone L; del Giudice EM J Pediatr Gastroenterol Nutr; 2014 Oct; 59(4):472-5. PubMed ID: 25250621 [TBL] [Abstract][Full Text] [Related]
18. The PNPLA3 I148M polymorphism is associated with insulin resistance and nonalcoholic fatty liver disease in a normoglycaemic population. Wang CW; Lin HY; Shin SJ; Yu ML; Lin ZY; Dai CY; Huang JF; Chen SC; Li SS; Chuang WL Liver Int; 2011 Oct; 31(9):1326-31. PubMed ID: 21745282 [TBL] [Abstract][Full Text] [Related]
19. A gene variant of PNPLA3, but not of APOC3, is associated with histological parameters of NAFLD in an obese population. Verrijken A; Beckers S; Francque S; Hilden H; Caron S; Zegers D; Ruppert M; Hubens G; Van Marck E; Michielsen P; Staels B; Taskinen MR; Van Hul W; Van Gaal L Obesity (Silver Spring); 2013 Oct; 21(10):2138-45. PubMed ID: 23512881 [TBL] [Abstract][Full Text] [Related]
20. PNPLA3 polymorphisms and liver aminotransferase levels in a Mexican American population. Li Q; Qu HQ; Rentfro AR; Grove ML; Mirza S; Lu Y; Hanis CL; Fallon MB; Boerwinkle E; Fisher-Hoch SP; McCormick JB Clin Invest Med; 2012 Aug; 35(4):E237-45. PubMed ID: 22863562 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]